Journal of Toxicology and Pharmacology

Research Article | J Toxic Pharm 2017; 1:017 | Open Access

Acute, Sub-Chronic Toxicity in Wistar Rats and Cytotoxicity Studies of Hydroethanolic Root Extract of Cassia Sieberiana DC

BAH Fatoumata1, KANE Yaghouba2, FALL Alioune Dior3, CABRAL Mathilde1, TOURE Aminata1, LAM-FAYE Absa1, DIOP Cheikh1, DIENG Serigne Ibra Mbacke3, DIOUF Amadou1 and FALL Mamadou1*

1Laboratoire de Toxicologie et Hydrologie, Université Cheikh Anta Diop, Dakar, Senegal
2Service de Pathologie médicale, d’anatomie pathologique et clinique ambulante à l’Ecole Inter-états des Sciences et Médecine Vétérinaires de Dakar (E.I.S.M.V.)
3Laboratoire de Pharmacognosie et de Botanique, Université Cheikh Anta Diop, Dakar, Senegal

*Correspondence to: mamadou3.fall@ucad.edu.sn

Copyright: © 2017 The Authors. Published by Scientific Open Access Journals LLC.

Citation: Fatoumata B, Yaghouba K, Dior FA, et al. Acute, Sub-Chronic Toxicity in Wistar Rats and Cytotoxicity Studies of Hydroethanolic Root Extract of Cassia Sieberiana DC. J Toxicol Pharmacol 2017; 1:017.

Received: 07 November 2017; Accepted: 21 December 2017; Published: 28 December 2017

Abstract

Acute and sub-chronic toxicity studies of hydroethanolic root extract of Cassia sieberiana (Caesalpiniaceae), a plant widely used in traditional medicine in Senegal, were carried out in Wistar rats. Cytotoxicity of this extract was studied on vervet monkey kidney cells by the MMT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl-tetrazolium bromide] method concurrently. In the acute toxicity study, five female rats (260 ± 10 g) were each administered a single oral dose (5000 mg/kg) of the hydroethanolic extract of C. Sieberiana root bark and observed for signs of acute toxicity for 14 days. In the sub-chronic toxicity study, the hydroethanolic extract at 500, 1000 and 2000 mg/kg was administered to sets of 6 Wistar rats daily for 28 days. Each set consisted of 3 males (278 ± 13g) and 3 females (260 ± 10 g). Urinalysis, haematological and biochemical analyses were carried out on urine, whole blood and serum samples. Histological studies of the liver, heart, and kidney tissues were also performed. The results showed that the acute and subchronic toxicity studies of hydroalcoholic root extract of C. sieberiana did not result in death among the animals; there were no signs of toxicity. However, the histological study showed the presence of necrotic and inflammatory cells in the hepatic parenchyma and a sinusoidal stasis at the end of 28 days. The cytotoxicity study on cell viability showed that the plant seems to be cytotoxic only at very high doses.

Keywords: Cassia sieberiana, in vivo, in vitro, Toxicity

Introduction

Cassia sieberiana DC (Caesalpiniaceae) is a very common plant in all Sudanese savannah. It is widely distributed throughout the southern Sahel and Sudan savannah from Senegal to Cameroun, up to Sudan and the Republic of Congo [1]. It is also found in most parts of Nigeria. It is a perennial savannah legume shrub or tree, up to 20 m high. The leaves, which are spirally arranged, contain short hairs and can be elliptical to ovate in shape. The fruit is a cylindrical pod which contains rusty to dark brown ellipsoid seeds. The whole plant has therapeutic virtues but it is almost always the roots which serve for preparations. Phytochemical analysis of the root and fruit pulp of the plant shows the presence of four principal active groups: tannins, saponins, quinones, which are diversely concentrated [2].

The aqueous decoctions of the root, stem bark and the fruit pulp have been used traditionally for the treatment of many diseases: inflammatory conditions, tiredness and joint pains, fever, malaria, diarrhoea, leprosy, bilharzia and stomach pains [2,3]. Other uses including improvement of lactation after childbirth and treatment of rheumatic conditions are noted (15). Authors have shown that C. sieberiana extracts possess antimicrobial, antifungal, antioxidant and anti-ulcerogenic activity [4-7].

Ethanolic and aqueous root extracts of C. sieberiana also have analgesic, anti-inflammatory, antiparasitic, myorelaxant and antispasmodic activity [8,9].

In a study, Obidah et al. [10] reported that oral administration of aqueous extract of C. sieberiana stem bark to rats resulted in hepatotoxicity at lower doses (20-60 mg/kg) and nephrotoxicity at higher doses (180 mg/kg). Earlier, Tamboura et al. [3] found that the lethal dose (LD50) of the aqueous leaves extract in mice was 24.4 mg/kg. Many studies of C. sieberiana have been performed on different organs [11-14]. Though the root extract of the plant is widely used for medicinal purposes, little data is available regarding its toxicity. Only an acute single-dose toxicity study has been reported [7,15]. However, the extract may have deleterious effects on the liver at high doses with prolonged administration [15]. In this study we investigated the in vivo acute and subacute toxicity in rats as well as the in-vitro cytotoxicity.

Materials & Methods

Materials

Plant material: The root bark of Cassia sieberiana was collected from the Garden for Experimentation of useful Plants of the Faculty of Medicine, Pharmacy and Dentistry at the University of Cheikh Anta Diop of Dakar (UCAD) and at Hann National Park of Dakar. It was identified and authenticated in the Botany and Plant Biology Laboratory of the Faculty of Medicine of UCAD.

Reagents and Chemical Test kits: aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT), creatinine and urea were purchased from BioSystems (Spain). Urine test strips, Labistix, were obtained from Laboratory Diagnostics (Siemens, France). Minimal Essential Medium (MEM Highveld Biological), Berberine chloride (CAS: 633-65-8, purity: >95%) solution of MTT, phosphate buffered saline (PBS) without Ca + Mg, DMSO were purchased from Sigma-Aldrich (France).

Animals: Female and male Wistar albino rats weighing 260 ± 10 g were used. The animals were housed three per cage maximum. They were fed a normal commercial pellet diet, they were given water ad libitum and maintained under laboratory conditions (temperature 22-24°C, relative humidity 60-70 %). The research was conducted in accordance with the internationally accepted principles for laboratory animal use and care.

Cells: VERO cells (from a vervet monkey kidney of Africa) purchased from the "Department of Veterinary and Tropical Diseases" (University of Pretoria, South Africa)

Methods

Preparation of hydroethanolic extract

The plant material was dried and grounded to a fine powder. One hundred grams (100 g) of the powdered root bark was mixed with 500 mL of water-ethanol mixture (20/80; v/v). The mixture was boiled at 70°C for 15 minutes. It was allowed to cool and then filtered using No. 1 Whatman filter paper. The obtained filtrate was concentrated by evaporation using a rotary evaporator. The pasty extract was completely dried at room temperature to obtain a dry extract which was then grounded into powder. The dry extract obtained (hydroethanolic extract: HEE) was dissolved in distilled water, and the resultant mixture was homogenized by stirring (5-10 min) using a magnetic stirrer. The volume of the solution administered to the animals was determined using their body mass.

In vivo study

Acute toxicity studies: Acute toxicity of the extract was determined by gavage in rats according to the Organisation for Economic Co-operation and Development (OECD) chemical tests guideline no. 420 adopted on December 17, 2001 (16). Five Wistar female rats weighing 260 ± 10 g were obtained from the animal unit (Toxicology Laboratory of Dakar University). A single oral dose of the extract was administered at 5000 mg/kg to each rat with an oral gavage needle. Mortality and general behaviour of the animals were observed over a 48-hour period. They were monitored for clinical signs of toxicity including piloerection, lachrymatory, locomotor and respiratory activities for a period of 14 days.

Sub-chronic toxicity studies: Four groups of six rats (3 females: 260 ± 10g and 3 males: 278 ±13g) were force-fed by mouth daily for 28 days. Group 1 was kept as control and received normal tap water. Group 2, 3 and 4 were treated respectively with 500, 1000 and 2000 mg/kg of hydroethanolic extract of C. sieberiana . Animals in each group were weighed on day zero (baseline) and weekly thereafter. Rat blood samples in each group were collected into tubes with or without anticoagulant at the end of treatment; they were centrifuged at 4000rpm for 5 minutes and the resulting serum taken for biological tests.

Urinalysis: Rat urine samples were collected and analysed every week for glucose, ketones, and proteins, using urine reagent strips (Labistix, Siemens) from Diagnostic Laboratory Inc., France.

Haematological analysis: Red blood cells (RBC), mean cell volume (MCV), haematocrit (HCT), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC), white blood cells (WBC), haemoglobin (HGB) and platelet counts (PLT) were determined with an automated haematology analyser (MIN-BC-3000Plus auto hematology analyzer, Mindray).

Serum biochemical analyses: Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood sugar and creatinine of samples were determined according to the protocols of Biosystems diagnostic kits (Spain) with a semi-automated blood chemistry analyser (A15 Biosystems, Barcelone).

Histology: At the end of treatment, rats were sacrificed by cervical dislocation and the heart, liver and kidney were excised. All organs were stored in 10 % neutral formalin and dehydrated in ethanol. The tissues were then cleared with chloroform and impregnated into paraffin wax. Five µm thick sections were mounted on slides and stained with haematoxylin and eosin for light microscopic examinations.

In vitro study: Cytotoxicity assay

Cytotoxicity of hydroethanolic root extract of Cassia sieberiana was determined using a tetrazolium-based colorimetric assay (MTT assay) described by Mosmann (1983) (18). Vero monkey kidney cells were harvested and centrifuged at 200 × g for 5 minutes. The pellet was re-suspended in growth medium and seeded at a density of 2.4 × 103cells/mL using Minimal essential medium (MEM) (Highveld Biological, South Africa) supplemented with 0.1% gentamicin (Sigma) and 10% foetal calf serum (Highveld Biological, South Africa). After 24 hours of incubation at 37°C, the medium on cells was removed and 200 μL of test plant extract or berberine chloride (Sigma) (positive control) was added at various concentrations (quadruplicate dilutions prepared in growth medium). Cells were further incubated at 37°C in a 5% CO2 incubator for 5 days. Thereafter, 30 μL MTT (stock solution of 5 mg/mL in phosphate– buffered saline) was added to each well and the plates were incubated for 4 hours at 37°C. The medium was carefully removed by aspiration and the MTT crystals were dissolved into formazan by adding 50 μL of DMSO to each well. The absorbance, proportional to the amount of MTT reduced, was measured at 570 nm using a microplate reader (Versamax). The LC50 values were calculated as the concentration of plant extract resulting in a 50% reduction of absorbance compared to untreated cells from a linear regression equation. LC50 values are expressed as the mean of three independent triplicate assays and values were expressed as mean of quadruplicate assays.

Statistical analysis

Results were analysed using Student's t test. A p-value less than 0.05 was considered significant compared to the control.

Results

In vivo study

Acute toxicity studies: No animal mortality was induced by the single dose of the extract given at 5000 mg/kg. Furthermore, the animals did not show toxicity signs or visible changes in locomotion and respiration.

Sub-chronic toxicity studies: No deaths were observed; no significant clinical relevant changes were observed in general behaviour and other physiological activities in this study.

Body weight

The evolution of body weight during the treatment is shown in Figure 1 and Figure 2. The results showed no significant difference (p >0.05) in body weight changes between C. sieberiana -treated and control animals.

 Figure 1: Effect of oral administration of hydroethanolic root extract of Cassia sieberiana on female rats’ body weights (n =3). Treated groups were compared to controls using student’s t test. Data are mean ± SEM and P values less than 0.05 were considered significant.

 Figure 2: Effect of oral administration of hydroethanolic root extract of Cassia sieberiana on male rats’ body weights (n =3). Treated groups were compared to controls using student’s t test. Data are mean ± SEM and P values less than 0.05 were considered significant.

Biochemistry analysis

The results of biochemical serum parameters at the end of treatment are shown in Table 1. These results show that parameters of the treated animals did not significantly differ from those of control rats. (p < 0.05). Similarly, there were no significant changes in the urinalysis data between C. sieberiana root-treated animals and controls.

 Table 1: Effect of hydroethanolic root extract of Cassia sieberiana on biochemical serum parameters.

Haematological results

The effect of sub-chronic administration of hydroethanolic extract of Csieberiana on haematological indices is shown in Table 2. The results show that there were no significant differences (p >0.05) in all parameters measured between control and C. sieberiana -treated animals.

 Table 2: Effect of hydroethanolic root extract of Cassia sieberiana on haematological parameters.

Histological results

Macroscopic examination of tissues shows that C.sieberina extract did not affect liver, kidney and heart morphology.

Minor histopathological effect was seen only in liver as scant centrolobular necrosis, slight inflammatory response and stasis (Figure 3a, 3b and 3c).

 Figure 3: (a), (b) and (c): Histological features of Rat liver. Minor lesion changes observed on livers of the rats orally received hydroethanolic root extract of Cassia sieberiana.

Cytotoxicity study

Results of cytoxicity are shown in Table 3.

 Table 3: Percentage of viability of kidney cells between products and control.

It is noted that cell viability decreased as and as the dose of extract increases. The hydroethanolic root extract of C. sieberiana had a LC50 value higher than that of berberine used as positive control (12.76 ± 0.91 μg/ml versus 9.99 ± 0.54 μg/mL respectively) as shown in Figure 4.

 Figure 4: LC50 (in μg/ml) extract and berberine.

Discussion

In the present work, we evaluated the acute & sub-chronic toxicity of root extract of C. sieberiana in Wistar rats and cytotoxicity on Vero cells. The limit dose of 5000 mg/kg did not result in mortality or any clinical sign of acute toxicity in animals in the short-term (48 hours) and long-term (14 days) observatory periods, suggesting that the oral LD50 of the extract is more than 5000 mg/kg in rats. The limit test is used in situations where the investigator has information indicating that the test material is likely to be non-toxic or of low toxicity [16]. The same result was found by Donkor et al. [15] who had evaluated the acute and sub-chronic toxicity of aqueous extract of Cassia sieberianaD.C root bark in rodents (rats and mice), [15]. In a previous study, the oral LD50 of root of C. sieberiana in rats was estimated to be more than 2000 mg/kg [7]. Therefore, the result of the acute oral toxicity study suggests that C. sieberiana root tested at the limit dose is essentially non-toxic (scale of Hodge and Sterner) [17].

In the subchronic toxicity study, the extract did not affect the normal growth of the animals as evidenced by comparing the body weight gain in both control and treated animals over the 28-day treatment period. There were no significant changes in the macroscopic aspects of heart, kidney and liver. The liver and kidney are important organs of the body which play a vital role in metabolic processes. The liver detoxifies substances that are harmful to the body. The kidney helps in maintaining homeostasis of the body by reabsorbing vital substances and excreting waste products [18]. In the present work, the biochemical analysis showed no significant elevation in serum ALT, AST, glucose and creatinine in treated animals compared to controls. However, the histological study showed necrosis of hepatic cells, which could be caused by the substance (specify name of substance you’re referring). This is confirmed by Donkor et al in their study [15], which showed elevated levels of ALP and total bilirubin in blood [15]. The serum ALT and AST are sensitive indicators of hepatocellular damage [19]. High levels are present within hepatocytes (Within healthy or damaged hepatocytes? Consider omitting this whole part since this is being repeated in detail in the next phrase) and plasma levels rise as hepatocyte membrane integrity is disturbed during hepatocellular injury [20,21]. Creatinine is the most reliable renal marker and increases only when the majority of renal function is lost [22].

In contrast, Obidah et al. [10] have demonstrated that oral administration of the stem bark extract to rats resulted in significant increase in ALT and AST levels. This difference could be explained by the part of the plant used.

There were no significant differences between urinalysis parameters of treated and control animals. The extract may not have deleterious effects on the haematological system since the parameter values (Table 2) did not vary when compared to control rats.

Histological examination of hepatocytes of the treated rats, stained with haematoxylin and eosin, revealed slight centrilobular necrosis, inflammatory cells and sinusoidal stasis in the liver parenchyma. Thus, the extract may have a deleterious effect on the liver after 28 days of exposure to C sieberiana root extract. A result obtained by Donkor et al. [15] indicated a slight necrosis centrilobular of liver cells after 3 months of treatment at the highest dose. This suggests that root extract of Cassia sieberiana may be toxic to the liver in the short or long term. The kidney and heart did not show noticeable morphological or microscopic changes in all the treated rats.

Several studies have shown that the MTT assay is sensitive, accurate, convenient, fast and economical for the study of cytotoxicity. In this work, the MTT assay showed an IC50 at 12.76 μg/ml. This means that the extract was less toxic than the positive control with 9.99 μg/ml. Berberine, which has been used as a reference, is a natural toxin of several plants of the family Berberidaceae . It is found in Coptis sinensis,used as a medicinal plant in China, and in Hydrastiscanadensis as a dietary supplement [23]. This suggests that its content in these plants commonly used by humans does not present any danger.

The inhibition of cell viability effect increases proportionally to concentration. This suggests that the extract may be toxic at high doses.

Conclusion

We concluded that the oral toxicity of the hydroethanolic root extract of the C. sieberiana in rats was found to be low (oral LD50 > 5000 mg/kg). However, the extract may have deleterious effects on the liver at high doses with prolonged administration. These results suggest that its usage in traditional medicine should be limited to moderate doses on a short-term basis.

References

  1. Michael A. Trees, shrubs and lianas of West Africa dry zones. Ciriad Magraf publisher Netherlands. 2004.
  2. Madusolomuo MA, Nadro MS, Wurocheke AU. Antihepatotoxic properties of Cassia sieberiana in acetaminophen–treated rats. Nigerian journal of biochemistry and molecular biology. 1999; 14:21-25.
  3. Tamboura HH, Bayala B, Lompo M, Guissou IP, Sawadogo L. Ecological Distribution, Morphological Characteristics And Acute Toxicity Of Aqueous Extracts Of Holarrhena Floribunda (G. DON) Durand & Schinz, Leptadenia hastata (PERS.) Decne and Cassiasieberiana (DC) Used By Veterinary Healers In Burkina Faso. African Journal of Traditional, Complementary and Alternative Medicines. 2005; 2:13-24.
  4. Silva O, Barbosa S, Diniz A, Valdeira ML, Gomes E. Plant extracts antiviral activity against Herpes simplex virus type 1 and African swine fever virus. Pharmaceutical Biology. 1997a; 35:12-16.
  5. Silva O, Ferreira E, VazPato M, Gomes E. Guinea-Bissau's plants: in vitro susceptibility studies on Neisseria gonorrhoeae. Pharmaceutical Biology. 1997b; 35:323-328.
  6. Asase A, Kokubun T, Grayer RJ, Kite G, Simmonds MS, Oteng-Yeboah AA, et al. Chemical constituents and antimicrobial activity of medicinal plants from Ghana: Cassia sieberiana, Haematostaphis barteri, Mitragyna inermis and Pseudocedrela kotschyi . Phytotherapy research. 2008; 22:1013-1016.
  7. Nartey ET, Ofosuhene M, Kudzi W, Agbale CM. Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberianaroot bark extract as an anti-ulcerogenic agent. Complementary and Alternative Medicine. 2012; 12:65.
  8. Duwiejua M, Panyin AB, Weremfo A, Woode E, Ansah C. Antinociceptive activity of the ethanolic extract of the root bark of Cassia sieberiana (Fam. Caesalpinaceae). Journal of Pharmacy & Bioresources. 2007; 4:49-58.
  9. Sy GY, Fall AD, Diatta W, Gueye M, Badji K, Bassène El. Analgesic and anti-inflammatory activity of aqueous root extract of Cassia sieberiana DC (Caesalpiniaceae). African Journal of Pharmacy and Pharmacology. 2009; 3:651-653.
  10. Obidah W, Sa’ad UA, Wurochekke AU. Toxic effects of aqueous stem bark extract of Cassia sieberiana on some biochemical parameters in rats. African Journal of Biochemistry Research. 2009; 3:229-231.
  11. Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN, Ray C. Screening of Indian plants for biological activity: I. Indian journal of experimental biology. 1968; 6:232-247.
  12. Mugera GM. Toxic and medicinal plants of East Africa.II Bulletin of epizootic diseases of Africa. Bulletin des epizooties en Afrique. 1970; 18:389-403.
  13. El Sayed NY, Abdelbari EM, Mahmoud OM, Adam SE. The toxicity of Cassia senna to Nubian goats. The Veterinary quarterly. 1983; 5:80-85.
  14. Neuwinger HD. African ethnobotany: poisons and drugs: chemistry, pharmacology, toxicology. Weinheim:Chapman & Hall. 1996.
  15. Donkor K, Okine LNK, Abotsi WKM, Woode E. Acute and Sub-Chronic Toxicity Studies of Aqueous Extract of Root Bark of Cassia Sieberiana D.C. in Rodents. Journal of Applied Pharmaceutical Science. 2014; 4:084-089.
  16. OECD. OECD Guidelines for the Testing of Chemicals on Acute Oral Toxicity – Acute Toxic Class Method. No 423. 2001.
  17. Hodge HC, Sterner JH. Tabulation, toxicity classe.American Industrial Hygiene Association. Quart. 1949; 10:93-96.
  18. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods. 1983; 65:263- 271.
  19. Chawla R. Serum total protein and albumin-globulin ratio. In: (Methods and Interpretations) (eds Chawla R): Jaypee Brothers Medical Publishers, New Delhi, Indian Journal of Clinical Biochemistry. 1999; pp.106 -118.
  20. Chapatwala KD, Boykin MA, Rajanna B. Effects of intraperitoneally injected cadmium on renal and hepatic glycogenic enzymes in rats. DrugandChemical Toxicology. 1982 ;5:305-317.
  21. Kew ML. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet. 2000; 335:951-952.
  22. Galati EM, Mondello MR, Lauriano ER, Taviano MF, Galluzo M, Miceli N. Opuntia ficus indica (L) Mill fruit juice protects liver against carbon tetrachloride induced liver injury. Phytotherapy Research. 2005; 19:796-800.
  23. Borges LP, Borges VC, Moro AV, Nogueira CW, Rocha JB, Zeni G. Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology. 2005; 210:1-8.